GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Total Long-Term Liabilities

TaiMed Biologics (ROCO:4147) Total Long-Term Liabilities : NT$785.4 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. TaiMed Biologics's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was NT$785.4 Mil.

TaiMed Biologics Total Long-Term Liabilities Historical Data

The historical data trend for TaiMed Biologics's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Total Long-Term Liabilities Chart

TaiMed Biologics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,318.92 1,444.15 1,056.33 966.66 841.57

TaiMed Biologics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 948.60 910.74 864.38 841.57 785.44

TaiMed Biologics Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

TaiMed Biologics Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Total Long-Term Liabilities
Comparable Companies
ROCO:4728 ROCO:6589 ROCO:6547 ROCO:6535 ROCO:6617 ROCO:4743 ROCO:6712 TPE:6541 ROCO:4162 TPE:6550 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
Website
https://www.taimedbiologics.com
TaiMed Biologics Inc is a biotechnology company committed to have the expertise and capability in developing, manufacturing and commercializing new drugs for the treatment and prevention of infectious diseases. Its products include Trogarzo IV Infusion, Trogarzo IV Push, TMB-365, TMB-365/TMB-380 (TMB-365 and TMB-380 combination), and Antibody-Drug Conjugates, ADCs.

TaiMed Biologics Headlines

No Headlines